U.S. stocks rise on hopes for solid earnings, recovery; Dow gains 0.88%

Investing.com  |  Author 

Published Apr 10, 2013 04:17PM ET

Investing.com - U.S. stocks rose on Wednesday amid hopes that first-quarter results may outpace earlier expectations for modest improvements, while Federal Reserve language fanned hopes for the economy to gain steam in the coming months.

At the close of U.S. trading, the Dow Jones Industrial Average finished up 0.88%, the S&P 500 index rose 1.22%, while the Nasdaq Composite index rose 1.83%.

Earnings season is underway and hopes continued to build on Wednesday that top-line and bottom-line results may bring pleasant surprises in the coming weeks.

Meanwhile, the Federal Reserve released the minutes of its March monetary policy meeting earlier, which also pumped up share prices, especially when it comes to wrapping up stimulus programs.

The Fed is currently purchasing USD85 billion in mortgage debt and Treasury holdings held by banks a month, a monetary stimulus tool known as quantitative easing that pushes down interest rates and pumps the economy full of liquidity to encourage investing and hiring, which weakens the dollar and sends stocks rising as side effects.

Monetary authorities appear to be at odds over when to dismantle such stimulus programs.

"A few members felt that the risks and costs of purchases, along with the improved outlook since last fall, would likely make a reduction in the pace of purchases appropriate around midyear, with purchases ending later this year," the Fed said in the minutes.

"Several others thought that if the outlook for labor market conditions improved as anticipated, it would probably be appropriate to slow purchases later in the year and to stop them by year-end."

Investors in equities markets concluded that stocks win either way — either stimulus programs stay in effect longer and stocks rise on the liquidity surge, or the Fed winds down such programs on the conclusion that the economy is strengthening, which would also bring up share prices.

Investors also went long on Chinese data revealing the world's second-largest economy produced an unexpected trade surplus in March, as imports rose sharply, reflecting firming domestic demand.

U.S. technology and pharmaceutical companies performed particularly well.

Leading Dow Jones Industrial Average performers included Merck, up 2.94%, Pfizer, up 2.82%, and Cisco Systems, up 2.34%.

The Dow Jones Industrial Average's worst performers included Wal-Mart Stores, down 0.95%, Alcoa, down 0.83%, and Travelers Companies, down 0.55%.

European indices, meanwhile, finished higher.

After the close of European trade, the EURO STOXX 50 rose 2.56%, France's CAC 40 rose 1.99%, while Germany's DAX 30 finished up 2.27%. Meanwhile, in the U.K. the FTSE 100 gained 1.17%.

On Thursday, the U.S. is to release a weekly government report on initial jobless claims and official data on import prices.









Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes